Celgene Corporation
CELGENE CORP /DE/ (Form: 4, Received: 03/14/2014 16:04:29)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HUGIN ROBERT J
2. Issuer Name and Ticker or Trading Symbol

CELGENE CORP /DE/ [ CELG ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
see remarks
(Last)          (First)          (Middle)

C/O CELGENE CORPORATION, 86 MORRIS AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

3/13/2014
(Street)

SUMMIT, NJ 07901
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/13/2014     M    7897   A $59.01   481561   D    
Common Stock   3/13/2014     M    17139   A $42.39   498700   D    
Common Stock   3/13/2014     M    25168   A $42.39   523868   D    
Common Stock   3/13/2014     M    5000   A $12.585   528868   D    
Common Stock   3/13/2014     M    40000   A $15.49   568868   D    
Common Stock   3/13/2014     F    39578   D $156.00   529290   D    
Common Stock                  4800   (1) I   By Children  
Common Stock                  13589   I   401(k) Plan  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   $59.01   3/13/2014     M         7897      (2) 7/6/2014   Common Stock   7897   $0.00   (3) 0   D    
Stock Option (right to buy)   $42.39   3/13/2014     M         17139      (2) 7/6/2014   Common Stock   17139   $0.00   (3) 0   D    
Stock Option (right to buy)   $42.39   3/13/2014     M         25168      (2) 4/6/2014   Common Stock   25168   $0.00   (3) 0   D    
Stock Option (right to buy)   $12.585   3/13/2014     M         5000      (2) 1/4/2015   Common Stock   5000   $0.00   (3) 0   D    
Stock Option (right to buy)   $15.49   3/13/2014     M         40000      (2) 10/5/2014   Common Stock   40000   $0.00   (3) 0   D    

Explanation of Responses:
( 1)  The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
( 2)  The option was fully exercisable.
( 3)  The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).

Remarks:
Chairman of the Board of Directors, Chief Executive Officer and President

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HUGIN ROBERT J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT, NJ 07901
X
see remarks

Signatures
/s/Robert J Hugin____________________ Robert J Hugin 3/14/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.